Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2297614 | 0.96 | ALDH1A1 (0.50) | ALDH1A1TSHRCYP2C9 | |
| SCHEMBL1990973 | 0.92 | ALDH1A1 (0.51) | ALDH1A1TSHRCYP2C9MGAMGAA | |
| SCHEMBL1987524 | 0.91 | TSHR (0.50) | ALDH1A1TSHRCYP2C9GAAMEN1 | |
| SCHEMBL1990863 | 0.88 | ALDH1A1 (0.57) | ALDH1A1TSHRCYP2C9MGAMGAA | |
| SCHEMBL15519449 | 0.85 | ALDH1A1 (0.53) | ALDH1A1TSHRTDP1 | |
| SCHEMBL12335165 | 0.82 | MGAM (0.39) | ALDH1A1TSHRMGAMGAASI | |
| SCHEMBL15519639 | 0.82 | ALDH1A1 (0.50) | ALDH1A1TSHR | |
| SCHEMBL540851 | 0.81 | ALDH1A1 (0.59) | ALDH1A1TSHRCYP2C9MGAMGAA | |
| SCHEMBL1984781 | 0.80 | ALDH1A1 (0.54) | ALDH1A1TSHRCYP2C9MGAMGAA | |
| SCHEMBL3183024 | 0.79 | TSHR (0.47) | ALDH1A1TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2515954-A1 | OXIDIZED REGENERATED CELLULOSE ADHESIVE TAPE | Advanced Technologies and Regenerative Medicine, LLC (US) | 2012-10-31 | — | — | EP | claimed |
| WO-2011087722-A1 | OXIDIZED REGENERATED CELLULOSE ADHESIVE TAPE | ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC (US) | 2011-07-21 | — | — | WO | claimed |
| US-20110152924-A1 | OXIDIZED REGENERATED CELLULOSE ADHESIVE TAPE | ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC | 2011-06-23 | — | — | US | claimed |
| US-8475825-B2 | Cyanoacrylate initiator system | ETHICON, INC. (US) | 2013-07-02 | — | — | US | disclosed |
| EP-2515954-A1 | OXIDIZED REGENERATED CELLULOSE ADHESIVE TAPE | Advanced Technologies and Regenerative Medicine, LLC (US) | 2012-10-31 | — | — | EP | disclosed |
| US-8287202-B2 | Method for dispensing a polymerizable monomer adhesive | ETHICON, INC. (US) | 2012-10-16 | — | — | US | disclosed |
| US-8287202-B2 | Method for dispensing a polymerizable monomer adhesive | ETHICON, INC. (US) | 2012-10-16 | — | — | US | disclosed |
| US-20120160867-A1 | DISPENSER WITH A FRANGIBLE CONTAINER AND A ROTATING BREAKING MEMBER, FOR DISPENSING A POLYMERIZABLE MONOMER ADHESIVE | CLOSURE MEDICAL CORPORATION | 2012-06-28 | — | — | US | disclosed |
| US-20120160867-A1 | DISPENSER WITH A FRANGIBLE CONTAINER AND A ROTATING BREAKING MEMBER, FOR DISPENSING A POLYMERIZABLE MONOMER ADHESIVE | CLOSURE MEDICAL CORPORATION | 2012-06-28 | — | — | US | disclosed |
| US-8153743-B2 | Controlled exotherm of cyanoacrylate formulations | CLOSURE MEDICAL CORPORATION (US) | 2012-04-10 | — | — | US | disclosed |
| US-8118508-B2 | Dispenser with a frangible container and a rotating breaking member, for dispensing a polymerizable monomer adhesive | CLOSURE MEDICAL CORPORATION (US) | 2012-02-21 | — | — | US | disclosed |
| WO-2007106688-A1 | A METHOD FOR PRODUCING A CYANOACRYLATE MONOMER | ETHICON, INC. (US) | 2007-09-20 | — | — | WO | disclosed |
| US-20070213553-A1 | Method for producing a cyanoacrylate monomer | ETHICON, INC. | 2007-09-13 | — | — | US | disclosed |
| US-20070213553-A1 | Method for producing a cyanoacrylate monomer | ETHICON, INC. | 2007-09-13 | — | — | US | disclosed |
| US-20070213553-A1 | Method for producing a cyanoacrylate monomer | ETHICON, INC. | 2007-09-13 | — | — | US | disclosed |
| US-7238828-B2 | Absorbable α-cyanoacrylate compositions | ETHICON, INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-7238828-B2 | Absorbable α-cyanoacrylate compositions | ETHICON, INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-7238828-B2 | Absorbable α-cyanoacrylate compositions | ETHICON, INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-20060216266-A1 | Absorbable alpha-cyanoacrylate compositions | ETHICON, INC. | 2006-09-28 | — | — | US | disclosed |
| WO-2006102385-A1 | ABSORBABLE ALPHA-CYANOACRYLATE COMPOSITIONS | ETHICON, INC. (US) | 2006-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213553-A1 | Method for producing a cyanoacrylate monomer | FGB, PCCA, ALDOA | ALDH1A1 296/4885TSHR 4558/4885CYP2C9 2843/4885 |
| US-20060216266-A1 | Absorbable alpha-cyanoacrylate compositions | GJA1, HBG1, GLRA1 | ALDH1A1 588/4885TSHR 3872/4885CYP2C9 939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.